Exactech Polyethylene Orthopedic
Centralized before Judge Nicholas G. Garaufis in the Eastern District of New York in October 2022, the Exactech Polyethylene Orthopedic litigation consolidates federal claims alleging that a manufacturing and packaging defect — vacuum-sealed bags that failed to adequately exclude oxygen — caused premature oxidative degradation in Exactech knee, hip, and ankle implant components, leading to accelerated wear, loosening, and implant failure requiring revision surgery. The near-total overlap between total filings and currently pending actions (1,838 of 1,847) indicates a docket still in an early-to-middle stage of development, with little of the original claim volume yet resolved through settlement or dismissal.
What will primarily drive this docket's duration and resolution path is how cleanly the packaging-defect theory functions as a general-causation story across a large, multi-joint product line. A manufacturing and packaging defect that can be traced through Exactech's own quality-control and supply-chain records tends to support more coordinated resolution than litigation built on a diffuse or disputed causation theory, because it narrows the scientific fight to a discrete, documentable failure mechanism rather than an open question about whether the product category can cause the injury at all. The remaining variable is how much individualized proof — implant lot, time-in-place, and revision-surgery findings — the court requires before claims can be grouped for bellwether purposes.
Because the docket has not yet reached bellwether selection, the near-term structural signal to watch is how quickly the court and parties move from general discovery into a defined bellwether pool, since that transition is typically the clearest marker of a mass tort's shift from claim-building to resolution-oriented pretrial work. Criterica Intelligence's platform tracks that kind of procedural-milestone progression across every active MDL, offering a structural read on pace and posture without projecting any individual implant claim's outcome.
Plaintiffs allege that vacuum-sealed packaging failed to adequately exclude oxygen, causing the polyethylene components in knee, hip, and ankle implants to degrade prematurely and fail, often requiring revision surgery.
With 1,838 of 1,847 total actions still pending, the docket has resolved very little of its original claim volume, indicating it remains in an early-to-middle pretrial stage rather than approaching resolution.
A defect linked to documented manufacturing and packaging records tends to narrow the general-causation fight to a discrete mechanism, which can support more coordinated resolution than litigation built on a more diffuse causation theory.
The transition from general discovery into a defined bellwether pool is typically the clearest signal that a mass tort is shifting from claim-building toward resolution-oriented pretrial work.
Statistics shown reflect historical or illustrative model outputs derived from real case data. They are not predictions or guarantees of any individual outcome. Litigation results depend on facts, jurisdiction, judge, and counsel, and vary case by case. Model accuracy is subject to selection effects and changing legal dynamics.